These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9310827)
1. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Nagelkerken L; Blauw B; Tielemans M Int Immunol; 1997 Sep; 9(9):1243-51. PubMed ID: 9310827 [TBL] [Abstract][Full Text] [Related]
2. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ; Kennedy KJ; Smith WS; Miller SD J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821 [TBL] [Abstract][Full Text] [Related]
5. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K; Chandler P; Altmann DM Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820 [TBL] [Abstract][Full Text] [Related]
7. IFN-beta modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse. Luca ME; Visser L; Lucas CJ; Nagelkerken L J Neuroimmunol; 1999 Dec; 100(1-2):190-6. PubMed ID: 10695729 [TBL] [Abstract][Full Text] [Related]
8. Male SJL mice do not relapse after induction of EAE with PLP 139-151. Bebo BF; Vandenbark AA; Offner H J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079 [TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes. Vandenbark AA; Vainiene M; Ariail K; Miller SD; Offner H J Neurosci Res; 1996 Aug; 45(4):430-8. PubMed ID: 8872903 [TBL] [Abstract][Full Text] [Related]
10. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. Santambrogio L; Crisi GM; Leu J; Hochwald GM; Ryan T; Thorbecke GJ J Neuroimmunol; 1995 May; 58(2):211-22. PubMed ID: 7759610 [TBL] [Abstract][Full Text] [Related]
12. Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis. Di Rosa F; Francesconi A; Di Virgilio A; Finocchi L; Santilio I; Barnaba V Eur J Immunol; 1998 Dec; 28(12):3893-903. PubMed ID: 9862326 [TBL] [Abstract][Full Text] [Related]
13. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788 [TBL] [Abstract][Full Text] [Related]
14. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way. Berghmans N; Dillen C; Heremans H J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944 [TBL] [Abstract][Full Text] [Related]
15. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides. Falk K; Rötzschke O; Santambrogio L; Dorf ME; Brosnan C; Strominger JL J Exp Med; 2000 Feb; 191(4):717-30. PubMed ID: 10684863 [TBL] [Abstract][Full Text] [Related]
16. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Ramírez F; Mason D Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389 [TBL] [Abstract][Full Text] [Related]
17. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. Cua DJ; Coffman RL; Stohlman SA J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386 [TBL] [Abstract][Full Text] [Related]
18. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance. Kennedy KJ; Smith WS; Miller SD; Karpus WJ J Immunol; 1997 Jul; 159(2):1036-44. PubMed ID: 9218627 [TBL] [Abstract][Full Text] [Related]
19. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression. Imler TJ; Petro TM Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403 [TBL] [Abstract][Full Text] [Related]